Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L04 IMMUNOSUPPRESSANTS
L04A IMMUNOSUPPRESSANTS
L04AX Other immunosuppressants
L04AX07 Dimethyl fumarate
D03846 Dimethyl fumarate (JAN/USAN) <JP/US>
USP drug classification [BR:br08302]
Central Nervous System Agents
Multiple Sclerosis Agents
Dimethyl Fumarate
D03846 Dimethyl fumarate (JAN/USAN)
Therapeutic category of drugs in Japan [BR:br08301]
1 Agents affecting nervous system and sensory organs
11 Agents affecting central nervous system
119 Miscellaneous
1190 Miscellaneous
D03846 Dimethyl fumarate (JAN/USAN)
Target-based classification of drugs [BR:br08310]
Not elsewhere classified
Cellular process
Ubiquitin system
KEAP1
D03846 Dimethyl fumarate (JAN/USAN) <JP/US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D03846
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D03846
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D03846
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D03846